Suehiro T, Nakamura T, Inoue M, Shiinoki T, Ikeda Y, Kumon Y, Shindo M, Tanaka H, Hashimoto K
The Second Department of Internal Medicine, Kochi Medical School, Kohasu, Okoh-cho, Nankoku, 781-8505, Kochi, Japan.
Atherosclerosis. 2000 Jun;150(2):295-8. doi: 10.1016/s0021-9150(99)00379-2.
Human serum paraoxonase (PON1) is an esterase that has been shown to decrease the susceptibility of lipoproteins to lipid peroxidation. We found a polymorphism of cytosine/thymidine (-108C/T, the number is from the ATG codon) in the upstream region of the PON1 gene. The luciferase activity was lower in the -108T allele than in the -108C allele. The serum PON1 concentrations in 132 normal subjects were as follows: -108CC>-108CT and>-108TT genotypes. The polymorphism upstream from the PON1 gene is associated with transcription of the PON1 gene and the serum PON1 concentration.
人血清对氧磷酶(PON1)是一种酯酶,已被证明可降低脂蛋白对脂质过氧化的易感性。我们在PON1基因上游区域发现了一个胞嘧啶/胸腺嘧啶多态性(-108C/T,编号从ATG密码子起)。-108T等位基因的荧光素酶活性低于-108C等位基因。132名正常受试者的血清PON1浓度如下:-108CC基因型>-108CT基因型>-108TT基因型。PON1基因上游的多态性与PON1基因的转录及血清PON1浓度相关。